IUCRO-0031; Molecular and Pathological Correlates of Treatment Outcome in Patients with Thymoma and Thymic Carcinoma

Overview

The primary objective of this study is to obtain blood and tissue samples for laboratory evaluation.

Description

The primary objective of this study is to obtain blood and tissue samples for laboratory evaluation.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions: Thyroid Cancer
  • Age: Between 18 Years - 100 Years
  • Gender: Male or Female

Inclusion Criteria
Patient must have documented or suspected thymoma or thymic carcinoma and be able and willing to give written informed consent


Additional Information:
Participants will not be paid for their participation.

Updated on 20 Nov 2022 . Study ID: TX990

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center